Literature DB >> 30734854

Nanobody: outstanding features for diagnostic and therapeutic applications.

J-Pablo Salvador1,2, Lluïsa Vilaplana3,4, M-Pilar Marco3,4.   

Abstract

Nanobodies (Nbs) have arisen as an alternative to conventional antibodies (Abs) and show great potential when used as tools in different biotechnology fields such as diagnostics and therapy. Different approaches have been described for the production of Nbs and these methods face new challenges focused on improving yield, affinity, and reducing production costs. This review summarizes these challenges, and also the latest advances in the detection of different kinds of molecules, such as proteins and small molecules, and describes their potential use for noninvasive in vivo imaging and for in vitro assays. Moreover, the unique properties of Nbs are outlined like internalization, size, thermal and chemical stability, affinity, blood clearance, and labeling procedures. Concerning therapeutic applications, we highlight some already reported examples about Nbs being used for the treatment of several diseases such as cancer, neurodegenerative or infectious diseases among others. Finally, future trends, opportunities, and disadvantages are also discussed.

Entities:  

Keywords:  Diagnosis; Imaging; Immunoassays; Nanobody; Single-domain antibody; Therapeutic

Mesh:

Substances:

Year:  2019        PMID: 30734854     DOI: 10.1007/s00216-019-01633-4

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  42 in total

1.  Isolation of an escape-resistant SARS-CoV-2 neutralizing nanobody from a novel synthetic nanobody library.

Authors:  Dmitri Dormeshkin; Michail Shapira; Simon Dubovik; Anton Kavaleuski; Mikalai Katsin; Alexandr Migas; Alexander Meleshko; Sergei Semyonov
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

2.  Combining of synthetic VHH and immune scFv libraries for pregnancy-associated glycoproteins ELISA development.

Authors:  Dmitri Dormeshkin; Michail Shapira; Alena Karputs; Anton Kavaleuski; Ivan Kuzminski; Elena Stepanova; Andrei Gilep
Journal:  Appl Microbiol Biotechnol       Date:  2022-06-20       Impact factor: 5.560

3.  Preparation and identification of a single domain antibody specific for adenovirus vectors and its application to the immunoaffinity purification of adenoviruses.

Authors:  Yi Cheng; Yanxia Hao; Fuxiang Bao; Huimin Zhang; Yanlong Liu; Kexin Ao; Shan Fu; Qiyao Wu; Zhi Wang
Journal:  AMB Express       Date:  2022-06-20       Impact factor: 4.126

4.  Non-Invasive Detection of SARS-CoV-2 Antigen in Saliva versus Nasopharyngeal Swabs Using Nanobodies Conjugated Gold Nanoparticles.

Authors:  Manal Kamel; Sara Maher; Hanan El-Baz; Faten Salah; Omar Sayyouh; Zeinab Demerdash
Journal:  Trop Med Infect Dis       Date:  2022-06-13

Review 5.  Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy.

Authors:  Anne M Macpherson; Simon C Barry; Carmela Ricciardelli; Martin K Oehler
Journal:  J Clin Med       Date:  2020-09-14       Impact factor: 4.241

Review 6.  50 Years of Structural Immunology.

Authors:  Ian A Wilson; Robyn L Stanfield
Journal:  J Biol Chem       Date:  2021-05-03       Impact factor: 5.157

7.  Biochemistry, structure, and cellular internalization of a four nanobody-bearing Fc dimer.

Authors:  Eric Chabrol; Charline Fagnen; Sophie Landron; Estelle Marcheteau; Johann Stojko; Sophie-Pénélope Guenin; Mathias Antoine; Benjamin Fould; Gilles Ferry; Jean A Boutin; Catherine Vénien-Bryan
Journal:  Protein Sci       Date:  2021-06-17       Impact factor: 6.993

8.  Self-Assembled Nanobodies as Selectively Targeted, Nanostructured, and Multivalent Materials.

Authors:  Laura Sánchez-García; Eric Voltà-Durán; Eloi Parladé; Elisa Mazzega; Alejandro Sánchez-Chardi; Naroa Serna; Hèctor López-Laguna; Mara Mitstorfer; Ugutz Unzueta; Esther Vázquez; Antonio Villaverde; Ario de Marco
Journal:  ACS Appl Mater Interfaces       Date:  2021-06-15       Impact factor: 10.383

9.  A Single-Domain Antibody-Based Anti-PSMA Recombinant Immunotoxin Exhibits Specificity and Efficacy for Prostate Cancer Therapy.

Authors:  Yutong Xing; Keyuan Xu; Shixiong Li; Li Cao; Yue Nan; Qiyu Li; Wenjing Li; Zhangyong Hong
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

Review 10.  Prospects of Neutralizing Nanobodies Against SARS-CoV-2.

Authors:  Fangfang Chen; Zhihong Liu; Fan Jiang
Journal:  Front Immunol       Date:  2021-05-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.